» Articles » PMID: 19710263

Cross-sectional and Longitudinal Multilocus Sequence Typing of Pseudomonas Aeruginosa in Cystic Fibrosis Sputum Samples

Overview
Specialty Microbiology
Date 2009 Aug 28
PMID 19710263
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Multilocus sequence typing (MLST) is a genetic typing tool designed to provide information about the relatedness of isolates at the core genome level. The utility of MLST in regard to cystic fibrosis (CF)-related infection with Pseudomonas aeruginosa is unknown. The molecular clock speed of the MLST genes was studied using 219 colonies isolated longitudinally from 49 patients with CF. A cross-sectional study examining 27 to 46 colonies per sputum sample for samples from 16 patients was also undertaken. The molecular clock speed was estimated to be 2.05 x 10(-5) (upper 95% confidence limit) or 4.75 x 10(-6) (50% confidence limit) point mutations per nucleotide per year. In the cross-sectional study, 50% of patients were infected with more than one sequence type. There was evidence of point mutations, recombination events, and coinfection with epidemic and unique strains. A clonal complex that was highly genetically distinct from the rest of the P. aeruginosa population was identified. The MLST scheme uses genes with an appropriate clock speed and provides useful information about the genetic variation of P. aeruginosa within and between patients with CF.

Citing Articles

Therapeutic Interventions for Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.

Alqasmi M J Clin Med. 2024; 13(21).

PMID: 39518670 PMC: 11547045. DOI: 10.3390/jcm13216530.


Recombination in Bacterial Genomes: Evolutionary Trends.

Shikov A, Savina I, Nizhnikov A, Antonets K Toxins (Basel). 2023; 15(9).

PMID: 37755994 PMC: 10534446. DOI: 10.3390/toxins15090568.


Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients.

Llanos A, Achard P, Bousquet J, Lozano C, Zalacain M, Sable C Sci Rep. 2023; 13(1):14208.

PMID: 37648735 PMC: 10468528. DOI: 10.1038/s41598-023-41333-9.


Phenotypic and genotypic within-host diversity of Pseudomonas aeruginosa urinary isolates.

Cottalorda A, Dahyot S, Soares A, Alexandre K, Zorgniotti I, Etienne M Sci Rep. 2022; 12(1):5421.

PMID: 35354853 PMC: 8967880. DOI: 10.1038/s41598-022-09234-5.


Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.

Lozano C, Azcona-Gutierrez J, Van Bambeke F, Saenz Y PLoS One. 2018; 13(9):e0204167.

PMID: 30212579 PMC: 6136817. DOI: 10.1371/journal.pone.0204167.


References
1.
Smith E, Buckley D, Wu Z, Saenphimmachak C, Hoffman L, DArgenio D . Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A. 2006; 103(22):8487-92. PMC: 1482519. DOI: 10.1073/pnas.0602138103. View

2.
Ogle J, Janda J, Woods D, Vasil M . Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis. 1987; 155(1):119-26. DOI: 10.1093/infdis/155.1.119. View

3.
Spilker T, Coenye T, Vandamme P, LiPuma J . PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol. 2004; 42(5):2074-9. PMC: 404678. DOI: 10.1128/JCM.42.5.2074-2079.2004. View

4.
Henderson-Begg S, Livermore D, Hall L . Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J Antimicrob Chemother. 2006; 57(5):849-54. DOI: 10.1093/jac/dkl064. View

5.
Sener B, Koseoglu O, Ozcelik U, Kocagoz T, Gunalp A . Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol. 2001; 291(5):387-93. DOI: 10.1078/1438-4221-00144. View